Standards; Pharmaceutical/API Drug Impurities/Metabolites;
應用:
(1S,3S,5S)-2-((R)-2-((1r,3S,5R,7S)-3-hydroxyadamantan-1-yl)-2-((E)-(2-(5-(hydroxymethyl)furan-2-yl)ethylidene)amino)acetyl)-2-azabicyclo[3.1.0]hexane-3-carbonitrile is a derivative of Saxagliptin, which is a potent and selective reversible inhibitor of dipeptidyl peptidase-4, which is being developed for the treatment of type 2 diabetes. It is absorbed rapidly after oral administration and has a pharmacokinetic profile compatible with once daily dosing.